Presolicitation
CDER-2024-123839-Microfluidic Equipment for Organ-on-a-Chip Studies
FDA-RFQ-CDER-2024-123839
Food and Drug Administration, FDA Office of Acq Grant SVCS. Analytical Laboratory Instrument Manufacturing.
Response deadline
May 27, 2024 at 12:00 PM EDT
Closed 889 days ago. Posted May 21, 2024. Scheduled to archive June 11, 2024.
Get the next one like this from Food and Drug Administration by email, the day it is posted.Find my opportunities
This one closed in 2024
38 like it are open now in analytical laboratory instrument manufacturing
- Graphite Furnace Atomic Absorption Spectrometer
National Institute of Standards and Technology, Department of Commerce NIST
Sources soughtNAICS 334516Anywhere in the USNIST-MML-FY27-SS01Closes in 26 daysNov 28 - Sources Sought Notice for Mid-IR Optical Frequency Comb
National Institute of Standards and Technology, Department of Commerce NIST
Sources soughtNAICS 334516Anywhere in the USNIST-SS26-CHIPS-13Closes in 31 daysDec 3 - Sources Sought Notice for Continuous Wave Parametric Oscillator (CW OPO) Laser System
National Institute of Standards and Technology, Department of Commerce NIST
Sources soughtNAICS 334516Anywhere in the USNIST-SS26-CHIPS-16Closes in 33 daysDec 5
All 38 open in analytical laboratory instrument manufacturing
Description
As published on SAM.gov.
The U. S. Food & Drug Administration, (FDA) Office of Acquisition and Grants Services (OAGS) has a requirement to procure: CDER-2024-123839-Microfluidic Equipment for Organ-on-a-Chip Studies, on a sole source basis. The Food and Drug Administration (FDA) intends to award this Sole Source purchase order to Fluigent, Inc., located at: Fluigent, Inc., 73 Princeton St., Suite 310, N. Chelmsford, MA 01863, Phone (978)
269-0347, Email: fluigentinc@fl uigent.com.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
May 21, 2024
Presolicitation, originally sources sought
Due May 27, 2024 at 12:00 PM EDT. SAM.gov, notice bacf3fb077f741dfaf12e5c1e1b12257
Points of contact
- Emmanuel T. MbahEmmanuel.mbah@fda.hhs.gov2404027598